Filing Details

Accession Number:
0001438133-20-000019
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-28 18:03:33
Reporting Period:
2020-02-26
Accepted Time:
2020-02-28 18:03:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM Surgical & Medical Instruments & Apparatus (3841) 204327508
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1582779 Dick Allen C/O Tandem Diabetes Care, Inc.,
11075 Roselle Street
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-26 406 $73.73 10,406 No 4 M Indirect See Footnotes)
Common Stock Disposition 2020-02-26 380 $78.82 10,026 No 4 S Indirect See Footnotes)
Common Stock Acquisiton 2020-02-26 2,778 $73.73 39,778 No 4 M Indirect See Footnote
Common Stock Disposition 2020-02-26 2,599 $78.82 37,179 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect See Footnotes)
No 4 S Indirect See Footnotes)
No 4 M Indirect See Footnote
No 4 S Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Disposition 2020-02-26 406 $73.73 406 $73.73
Common Stock Warrant Disposition 2020-02-26 2,778 $73.73 2,778 $73.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-02-26 No 4 M Indirect
0 2020-02-26 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,500 Indirect See Footnotes
Common Stock 1,500 Indirect See Footnote(s)
Footnotes
  1. The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.73. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.
  2. The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein.
  3. The securities are held by the Allen Family Trust dated October 12, 1981.
  4. The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon.
  5. The securities are held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon.
  6. The expiration dates for this warrant are August 31, 2021 (271 shares) and July 3, 2022 (135 shares).
  7. The expiration dates for this warrant are August 31, 2021 (1,356 shares), May 25, 2022 (596 shares) and July 17, 2022 (826 shares).